N/A
N=355
Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
Gastro-Intestinal Disorder
Bottom Line
View on ClinicalTrials.gov: NCT03440047 ↗Enrolled (actual)
355
Serious AEs
1.1%
Results posted
Oct 2023
Primary outcome: Primary: Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis — 283 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Fuji Flim Processor VP-7000, Light Source BL-7000 (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Dec 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis |
283 | — |
Summary
The purpose of this study is to see if advanced endoscopic imaging may be helpful to accurately distinguish pathological tissue from normal tissue and guide therapy of endoscopically identified pathology.
Eligibility Criteria
Inclusion Criteria
- All patients age 18-100 undergoing planned upper or lower endoscopy at Mayo Clinic Rochester
- Informed Consent
Exclusion Criteria
- Patient unwilling to provide informed consent
Data sourced from ClinicalTrials.gov (NCT03440047). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.